La tomografia ad emissione nella patologia neurodegenerativa

Abstract

Get full access to this article

View all access options for this article.

References

Baron

Maziere

: 76Br bromospiperone binding sites demonstrated by positron emission tomography in progressive supranuclear palsy. J Cereb Blood Flow Metab, 6: 131–136, 1990.

Brooks

Ibanez

: Differing patterns of striatal 18F-Dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Ann Neurol, 28: 547–555, 1990.

De Voider

Francart

: Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration. Ann Neurol, 26: 239–247, 1989.

Eckelman

: Receptor site imaging. In: Gottschalk

Hohher

Potchen

, (eds). Williams & Wilkins, Baltimora, 2: 830–836, 1988.

Frackowiak

RSJ

Lenzi

: Quantitative measurement of cerebral blood flow and oxygen metabolism in man using 15 02 and positron emission tomography: Theory, procedures and normal values. J Comput Assist Tomogr, 4: 727–736, 1980.

Frackowiak

RSJ

Pozzilli

: Regional cerebral oxygen supply and utilization in dementia: A study with oxygen-I 5 and positro tomography. Brain, 104: 753–778, 1981.

Freeney

Baron

: Diaschisis. Stroke, 17: 817–827, 1986.

Frost

Smith

: In vivo binding of 3H-N-Methylspiperone to dopamine and serotonin receptors. Life Sci 1, 40: 987–995, 1987.

Grafton

Mazziotta

: A comparison of neurological, metabolic, structural and genetic evaluations in persons at risk for Huntington's disease. Ann Neurol, 28: 614–621, 1990.

10.

Haxby

Grady

: Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol, 47: 753–760, 1990.

11.

Leenders

Palmer

: Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J Neurol Neurosurg and Psychiat, 49: 853–856, 1986.

12.

Leonard

Novotnik

Neirinckx

: Technezium-99m d, 1-HM-PAO: A new radiopharmaceutical for SPECT imaging of regional brain perfusion using SPECT: A comparison with iodine-123 HIPDM. J Nucl Med, 27: 1819–1823, 1986.

13.

Metter

Kempler

: Cerebral glucose metabolism: Differences in Wernicke's, Brocas's and conduction aphasia. Arch Neurol, 47: 1235–1238, 1989.

14.

Perani

Vallar

: Aphasia and neglect after subcortical stroke: A clinical/cerebral perfusion study. Brain, 110: 1211–1229, 1987.

15.

Perani

Di Piero

: Remote effects of subcortical cerebrovascular lesions: A SPECT cerebral perfusion sudy. J Cereb Blood Flow Metab, 8: 560–567, 1988.

16.

Perani

Di Piero

: Tc99m HM-PAO SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med, 29: 1507–1514, 1988.

17.

Reivich

Alavi

: Glucose metabolic rate kinetic model parameter determination in humans: The lumped constants and rate constants for 18F-fluorodeoxiglucose and 11C-deoxyglucose. J Cereb Blood Flow Metab, 5: 179–192, 1985.

18.

Sokoloff

Reivich

: The 14C-deoxiglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem, 28: 897–916, 1977.

19.

Tedroff

Aquilonius

: Monoamine re-uptake sites in the human brain evaluated in vivo by means of 11 C-nomifensine and positron emission tomography: The effects of age and Parkinson's disease. Acta Neurol Scand, 77: 192–201, 1988.

20.

Vallar

Perani

: Recovery from aphasia and neglect after subcortical stroke: Neurophysiological and cerebral perfusion study. J Neurol Neurosurg Psychiat, 51: 1269–1276, 1988.

21.

Wise

RSJ

Bernardi

: Serial observations on the pathophysiology of acute stroke. Brain, 106: 197–222, 1983.